Interestingly, CD44 generated in HEK293 cells, which were cloned from human embryonic kidney, was glycosylated in the mAb target region of CD44, indicating that cancer cells leave this region unglycosylated and possibly, this provides a unique cancer cell target. This evidence concerns the gene CD44 and cancer.